SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 66.27 |
| Enterprise Value ($M) | 63.29 |
| Book Value ($M) | -2.17 |
| Book Value / Share | -0.00 |
| Price / Book | -68.32 |
| NCAV ($M) | -2.59 |
| NCAV / Share | -0.01 |
| Price / NCAV | -25.55 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -2.18 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.59 |
| Current Ratio | 0.77 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 3.67 |
| Assets | 4.09 |
| Liabilities | 6.27 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.04 |
| Operating Income | -12.00 |
| Net Income | -11.21 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -7.99 |
| Cash from Investing | 0.00 |
| Cash from Financing | 7.82 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D | Doris Wong Sing Ee | 70.00 | ||
| 13D | Lazar David E. | 15.84 | ||
| 13G/A | Armistice Capital, Llc | 9.99 | 278.03 | |
| 13G/A | Lind Global Fund II LP | 0.00 | -100.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 43,408 | 271,079 | 16.01 | |
| 36,221 | 330,208 | 10.97 | |
| 32,261 | 183,442 | 17.59 | |
| 32,972 | 110,287 | 29.90 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CTXR – Citius Pharmaceuticals, Inc. | CUE – Cue Biopharma, Inc. |
| CVKD – Cadrenal Therapeutics, Inc. | CYCN – Cyclerion Therapeutics, Inc. |
| CYRX – Cryoport, Inc. |